APO Research
Talk to an analyst

APO RESEARCH · REPORT

Prophylactic Gamma Globulin

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Prophylactic Gamma Globulin Market Analysis and Forecast 2026-2032

22 December 2025200 pages

Choose your research edition.

Industry ResearchProphylactic Gamma Globulin Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Prophylactic Gamma Globulin Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Prophylactic Gamma Globulin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prophylactic Gamma Globulin Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Prophylactic Gamma Globulin Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Prophylactic Gamma Globulin market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Prophylactic Gamma Globulin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Prophylactic Gamma Globulin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Prophylactic Gamma Globulin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Prophylactic Gamma Globulin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Prophylactic Gamma Globulin include CNBG, Takeda, Shenzhen Weiguang Biological, Beijing Tiantan Biological, CBPO, Sichuan Yuanda Shuyang, Shanghai RAAS, Pacific Shuanglin Bio-pharmacy and Grifols, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Prophylactic Gamma Globulin, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Prophylactic Gamma Globulin, also provides the sales of main regions and countries. Of the upcoming market potential for Prophylactic Gamma Globulin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Prophylactic Gamma Globulin sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Prophylactic Gamma Globulin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Prophylactic Gamma Globulin sales, projected growth trends, production technology, application and end-user industry.

Prophylactic Gamma Globulin Segment by Company

CNBG

Takeda

Shenzhen Weiguang Biological

Beijing Tiantan Biological

CBPO

Sichuan Yuanda Shuyang

Shanghai RAAS

Pacific Shuanglin Bio-pharmacy

Grifols

Hualan Biological

Beijing Bohui Innovation Biotechnology

Baxter

Octapharma

LFB Group

Kedrion Biopharma

BPL

Biotest

ADMA Biologics

Prophylactic Gamma Globulin Segment by Type

IVIg Liquid

IVIg Powder

Prophylactic Gamma Globulin Segment by Application

Autoimmune Disease

Immunodeficiency

Acute Infection

Prophylactic Gamma Globulin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prophylactic Gamma Globulin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prophylactic Gamma Globulin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prophylactic Gamma Globulin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Prophylactic Gamma Globulin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Prophylactic Gamma Globulin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Prophylactic Gamma Globulin sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Prophylactic Gamma Globulin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. IVIg Liquid Major Manufacturers Table 3. IVIg Powder Major Manufacturers Table 4. Global Prophylactic Gamma Globulin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Autoimmune Disease Major Manufacturers Table 6. Immunodeficiency Major Manufacturers Table 7. Acute Infection Major Manufacturers Table 8. Prophylactic Gamma Globulin Industry Trends Table 9. Prophylactic Gamma Globulin Industry Drivers Table 10. Prophylactic Gamma Globulin Industry Opportunities and Challenges Table 11. Prophylactic Gamma Globulin Industry Restraints Table 12. Global Prophylactic Gamma Globulin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Prophylactic Gamma Globulin Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Prophylactic Gamma Globulin Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Prophylactic Gamma Globulin Revenue Market Share by Region (2021-2026) Table 16. Global Prophylactic Gamma Globulin Revenue Market Share by Region (2027-2032) Table 17. Global Prophylactic Gamma Globulin Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 18. Global Prophylactic Gamma Globulin Sales by Region (2021-2026) & (k units) Table 19. Global Prophylactic Gamma Globulin Sales by Region (2027-2032) & (k units) Table 20. Global Prophylactic Gamma Globulin Sales Market Share by Region (2021-2026) Table 21. Global Prophylactic Gamma Globulin Sales Market Share by Region (2027-2032) Table 22. Global Prophylactic Gamma Globulin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Prophylactic Gamma Globulin Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Prophylactic Gamma Globulin Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Prophylactic Gamma Globulin Sales Market Share by Manufacturers (2021-2026) Table 26. Global Prophylactic Gamma Globulin Sales Price (US$/unit) of Manufacturers (2021-2026) Table 27. Global Prophylactic Gamma Globulin Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Prophylactic Gamma Globulin Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Prophylactic Gamma Globulin Manufacturers, Product Type & Application Table 30. Global Prophylactic Gamma Globulin Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Prophylactic Gamma Globulin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Prophylactic Gamma Globulin Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Prophylactic Gamma Globulin Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Prophylactic Gamma Globulin Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Prophylactic Gamma Globulin Revenue Market Share by Type (2021-2026) Table 37. Global Prophylactic Gamma Globulin Revenue Market Share by Type (2027-2032) Table 38. Global Prophylactic Gamma Globulin Sales by Type 2021 VS 2025 VS 2032 (k units) Table 39. Global Prophylactic Gamma Globulin Sales by Type (2021-2026) & (k units) Table 40. Global Prophylactic Gamma Globulin Sales by Type (2027-2032) & (k units) Table 41. Global Prophylactic Gamma Globulin Sales Market Share by Type (2021-2026) Table 42. Global Prophylactic Gamma Globulin Sales Market Share by Type (2027-2032) Table 43. Global Prophylactic Gamma Globulin Price by Type (2021-2026) & (US$/unit) Table 44. Global Prophylactic Gamma Globulin Price by Type (2027-2032) & (US$/unit) Table 45. Global Prophylactic Gamma Globulin Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Prophylactic Gamma Globulin Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Prophylactic Gamma Globulin Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Prophylactic Gamma Globulin Revenue Market Share by Application (2021-2026) Table 49. Global Prophylactic Gamma Globulin Revenue Market Share by Application (2027-2032) Table 50. Global Prophylactic Gamma Globulin Sales by Application 2021 VS 2025 VS 2032 (k units) Table 51. Global Prophylactic Gamma Globulin Sales by Application (2021-2026) & (k units) Table 52. Global Prophylactic Gamma Globulin Sales by Application (2027-2032) & (k units) Table 53. Global Prophylactic Gamma Globulin Sales Market Share by Application (2021-2026) Table 54. Global Prophylactic Gamma Globulin Sales Market Share by Application (2027-2032) Table 55. Global Prophylactic Gamma Globulin Price by Application (2021-2026) & (US$/unit) Table 56. Global Prophylactic Gamma Globulin Price by Application (2027-2032) & (US$/unit) Table 57. CNBG Company Information Table 58. CNBG Business Overview Table 59. CNBG Prophylactic Gamma Globulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 60. CNBG Prophylactic Gamma Globulin Product Portfolio Table 61. CNBG Recent Development Table 62. Takeda Company Information Table 63. Takeda Business Overview Table 64. Takeda Prophylactic Gamma Globulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 65. Takeda Prophylactic Gamma Globulin Product Portfolio Table 66. Takeda Recent Development Table 67. Shenzhen Weiguang Biological Company Information Table 68. Shenzhen Weiguang Biological Business Overview Table 69. Shenzhen Weiguang Biological Prophylactic Gamma Globulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. Shenzhen Weiguang Biological Prophylactic Gamma Globulin Product Portfolio Table 71. Shenzhen Weiguang Biological Recent Development Table 72. Beijing Tiantan Biological Company Information Table 73. Beijing Tiantan Biological Business Overview Table 74. Beijing Tiantan Biological Prophylactic Gamma Globulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Beijing Tiantan Biological Prophylactic Gamma Globulin Product Portfolio Table 76. Beijing Tiantan Biological Recent Development Table 77. CBPO Company Information Table 78. CBPO Business Overview Table 79. CBPO Prophylactic Gamma Globulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. CBPO Prophylactic Gamma Globulin Product Portfolio Table 81. CBPO Recent Development Table 82. Sichuan Yuanda Shuyang Company Information Table 83. Sichuan Yuanda Shuyang Business Overview Table 84. Sichuan Yuanda Shuyang Prophylactic Gamma Globulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Sichuan Yuanda Shuyang Prophylactic Gamma Globulin Product Portfolio Table 86. Sichuan Yuanda Shuyang Recent Development Table 87. Shanghai RAAS Company Information Table 88. Shanghai RAAS Business Overview Table 89. Shanghai RAAS Prophylactic Gamma Globulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Shanghai RAAS Prophylactic Gamma Globulin Product Portfolio Table 91. Shanghai RAAS Recent Development Table 92. Pacific Shuanglin Bio-pharmacy Company Information Table 93. Pacific Shuanglin Bio-pharmacy Business Overview Table 94. Pacific Shuanglin Bio-pharmacy Prophylactic Gamma Globulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Pacific Shuanglin Bio-pharmacy Prophylactic Gamma Globulin Product Portfolio Table 96. Pacific Shuanglin Bio-pharmacy Recent Development Table 97. Grifols Company Information Table 98. Grifols Business Overview Table 99. Grifols Prophylactic Gamma Globulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Grifols Prophylactic Gamma Globulin Product Portfolio Table 101. Grifols Recent Development Table 102. Hualan Biological Company Information Table 103. Hualan Biological Business Overview Table 104. Hualan Biological Prophylactic Gamma Globulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Hualan Biological Prophylactic Gamma Globulin Product Portfolio Table 106. Hualan Biological Recent Development Table 107. Beijing Bohui Innovation Biotechnology Company Information Table 108. Beijing Bohui Innovation Biotechnology Business Overview Table 109. Beijing Bohui Innovation Biotechnology Prophylactic Gamma Globulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Beijing Bohui Innovation Biotechnology Prophylactic Gamma Globulin Product Portfolio Table 111. Beijing Bohui Innovation Biotechnology Recent Development Table 112. Baxter Company Information Table 113. Baxter Business Overview Table 114. Baxter Prophylactic Gamma Globulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. Baxter Prophylactic Gamma Globulin Product Portfolio Table 116. Baxter Recent Development Table 117. Octapharma Company Information Table 118. Octapharma Business Overview Table 119. Octapharma Prophylactic Gamma Globulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 120. Octapharma Prophylactic Gamma Globulin Product Portfolio Table 121. Octapharma Recent Development Table 122. LFB Group Company Information Table 123. LFB Group Business Overview Table 124. LFB Group Prophylactic Gamma Globulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 125. LFB Group Prophylactic Gamma Globulin Product Portfolio Table 126. LFB Group Recent Development Table 127. Kedrion Biopharma Company Information Table 128. Kedrion Biopharma Business Overview Table 129. Kedrion Biopharma Prophylactic Gamma Globulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 130. Kedrion Biopharma Prophylactic Gamma Globulin Product Portfolio Table 131. Kedrion Biopharma Recent Development Table 132. BPL Company Information Table 133. BPL Business Overview Table 134. BPL Prophylactic Gamma Globulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 135. BPL Prophylactic Gamma Globulin Product Portfolio Table 136. BPL Recent Development Table 137. Biotest Company Information Table 138. Biotest Business Overview Table 139. Biotest Prophylactic Gamma Globulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 140. Biotest Prophylactic Gamma Globulin Product Portfolio Table 141. Biotest Recent Development Table 142. ADMA Biologics Company Information Table 143. ADMA Biologics Business Overview Table 144. ADMA Biologics Prophylactic Gamma Globulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 145. ADMA Biologics Prophylactic Gamma Globulin Product Portfolio Table 146. ADMA Biologics Recent Development Table 147. North America Prophylactic Gamma Globulin Revenue by Type (2021-2026) & (US$ Million) Table 148. North America Prophylactic Gamma Globulin Revenue by Type (2027-2032) & (US$ Million) Table 149. North America Prophylactic Gamma Globulin Sales by Type (2021-2026) & (k units) Table 150. North America Prophylactic Gamma Globulin Sales by Type (2027-2032) & (k units) Table 151. North America Prophylactic Gamma Globulin Sales Price by Type (2021-2026) & (US$/unit) Table 152. North America Prophylactic Gamma Globulin Sales Price by Type (2027-2032) & (US$/unit) Table 153. North America Prophylactic Gamma Globulin Revenue by Application (2021-2026) & (US$ Million) Table 154. North America Prophylactic Gamma Globulin Revenue by Application (2027-2032) & (US$ Million) Table 155. North America Prophylactic Gamma Globulin Sales by Application (2021-2026) & (k units) Table 156. North America Prophylactic Gamma Globulin Sales by Application (2027-2032) & (k units) Table 157. North America Prophylactic Gamma Globulin Sales Price by Application (2021-2026) & (US$/unit) Table 158. North America Prophylactic Gamma Globulin Sales Price by Application (2027-2032) & (US$/unit) Table 159. North America Prophylactic Gamma Globulin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 160. North America Prophylactic Gamma Globulin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 161. North America Prophylactic Gamma Globulin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 162. North America Prophylactic Gamma Globulin Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 163. North America Prophylactic Gamma Globulin Sales by Country (2021-2026) & (k units) Table 164. North America Prophylactic Gamma Globulin Sales by Country (2027-2032) & (k units) Table 165. North America Prophylactic Gamma Globulin Sales Price by Country (2021-2026) & (US$/unit) Table 166. North America Prophylactic Gamma Globulin Sales Price by Country (2027-2032) & (US$/unit) Table 167. United States Prophylactic Gamma Globulin Revenue (2021-2032) & (US$ Million) Table 168. Canada Prophylactic Gamma Globulin Revenue (2021-2032) & (US$ Million) Table 169. Mexico Prophylactic Gamma Globulin Revenue (2021-2032) & (US$ Million) Table 170. Europe Prophylactic Gamma Globulin Revenue by Type (2021-2026) & (US$ Million) Table 171. Europe Prophylactic Gamma Globulin Revenue by Type (2027-2032) & (US$ Million) Table 172. Europe Prophylactic Gamma Globulin Sales by Type (2021-2026) & (k units) Table 173. Europe Prophylactic Gamma Globulin Sales by Type (2027-2032) & (k units) Table 174. Europe Prophylactic Gamma Globulin Sales Price by Type (2021-2026) & (US$/unit) Table 175. Europe Prophylactic Gamma Globulin Sales Price by Type (2027-2032) & (US$/unit) Table 176. Europe Prophylactic Gamma Globulin Revenue by Application (2021-2026) & (US$ Million) Table 177. Europe Prophylactic Gamma Globulin Revenue by Application (2027-2032) & (US$ Million) Table 178. Europe Prophylactic Gamma Globulin Sales by Application (2021-2026) & (k units) Table 179. Europe Prophylactic Gamma Globulin Sales by Application (2027-2032) & (k units) Table 180. Europe Prophylactic Gamma Globulin Sales Price by Application (2021-2026) & (US$/unit) Table 181. Europe Prophylactic Gamma Globulin Sales Price by Application (2027-2032) & (US$/unit) Table 182. Europe Prophylactic Gamma Globulin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 183. Europe Prophylactic Gamma Globulin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 184. Europe Prophylactic Gamma Globulin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 185. Europe Prophylactic Gamma Globulin Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 186. Europe Prophylactic Gamma Globulin Sales by Country (2021-2026) & (k units) Table 187. Europe Prophylactic Gamma Globulin Sales by Country (2027-2032) & (k units) Table 188. Europe Prophylactic Gamma Globulin Sales Price by Country (2021-2026) & (US$/unit) Table 189. Europe Prophylactic Gamma Globulin Sales Price by Country (2027-2032) & (US$/unit) Table 190. Germany Prophylactic Gamma Globulin Revenue (2021-2032) & (US$ Million) Table 191. France Prophylactic Gamma Globulin Revenue (2021-2032) & (US$ Million) Table 192. U.K. Prophylactic Gamma Globulin Revenue (2021-2032) & (US$ Million) Table 193. Italy Prophylactic Gamma Globulin Revenue (2021-2032) & (US$ Million) Table 194. Russia Prophylactic Gamma Globulin Revenue (2021-2032) & (US$ Million) Table 195. Spain Prophylactic Gamma Globulin Revenue (2021-2032) & (US$ Million) Table 196. Netherlands Prophylactic Gamma Globulin Revenue (2021-2032) & (US$ Million) Table 197. Switzerland Prophylactic Gamma Globulin Revenue (2021-2032) & (US$ Million) Table 198. Sweden Prophylactic Gamma Globulin Revenue (2021-2032) & (US$ Million) Table 199. Poland Prophylactic Gamma Globulin Revenue (2021-2032) & (US$ Million) Table 200. China Prophylactic Gamma Globulin Revenue by Type (2021-2026) & (US$ Million) Table 201. China Prophylactic Gamma Globulin Revenue by Type (2027-2032) & (US$ Million) Table 202. China Prophylactic Gamma Globulin Sales by Type (2021-2026) & (k units) Table 203. China Prophylactic Gamma Globulin Sales by Type (2027-2032) & (k units) Table 204. China Prophylactic Gamma Globulin Sales Price by Type (2021-2026) & (US$/unit) Table 205. China Prophylactic Gamma Globulin Sales Price by Type (2027-2032) & (US$/unit) Table 206. China Prophylactic Gamma Globulin Revenue by Application (2021-2026) & (US$ Million) Table 207. China Prophylactic Gamma Globulin Revenue by Application (2027-2032) & (US$ Million) Table 208. China Prophylactic Gamma Globulin Sales by Application (2021-2026) & (k units) Table 209. China Prophylactic Gamma Globulin Sales by Application (2027-2032) & (k units) Table 210. China Prophylactic Gamma Globulin Sales Price by Application (2021-2026) & (US$/unit) Table 211. China Prophylactic Gamma Globulin Sales Price by Application (2027-2032) & (US$/unit) Table 212. Asia Prophylactic Gamma Globulin Revenue by Type (2021-2026) & (US$ Million) Table 213. Asia Prophylactic Gamma Globulin Revenue by Type (2027-2032) & (US$ Million) Table 214. Asia Prophylactic Gamma Globulin Sales by Type (2021-2026) & (k units) Table 215. Asia Prophylactic Gamma Globulin Sales by Type (2027-2032) & (k units) Table 216. Asia Prophylactic Gamma Globulin Sales Price by Type (2021-2026) & (US$/unit) Table 217. Asia Prophylactic Gamma Globulin Sales Price by Type (2027-2032) & (US$/unit) Table 218. Asia Prophylactic Gamma Globulin Revenue by Application (2021-2026) & (US$ Million) Table 219. Asia Prophylactic Gamma Globulin Revenue by Application (2027-2032) & (US$ Million) Table 220. Asia Prophylactic Gamma Globulin Sales by Application (2021-2026) & (k units) Table 221. Asia Prophylactic Gamma Globulin Sales by Application (2027-2032) & (k units) Table 222. Asia Prophylactic Gamma Globulin Sales Price by Application (2021-2026) & (US$/unit) Table 223. Asia Prophylactic Gamma Globulin Sales Price by Application (2027-2032) & (US$/unit) Table 224. Asia Prophylactic Gamma Globulin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 225. Asia Prophylactic Gamma Globulin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 226. Asia Prophylactic Gamma Globulin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 227. Asia Prophylactic Gamma Globulin Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 228. Asia Prophylactic Gamma Globulin Sales by Country (2021-2026) & (k units) Table 229. Asia Prophylactic Gamma Globulin Sales by Country (2027-2032) & (k units) Table 230. Asia Prophylactic Gamma Globulin Sales Price by Country (2021-2026) & (US$/unit) Table 231. Asia Prophylactic Gamma Globulin Sales Price by Country (2027-2032) & (US$/unit) Table 232. Japan Prophylactic Gamma Globulin Revenue (2021-2032) & (US$ Million) Table 233. South Korea Prophylactic Gamma Globulin Revenue (2021-2032) & (US$ Million) Table 234. India Prophylactic Gamma Globulin Revenue (2021-2032) & (US$ Million) Table 235. Australia Prophylactic Gamma Globulin Revenue (2021-2032) & (US$ Million) Table 236. Taiwan Prophylactic Gamma Globulin Revenue (2021-2032) & (US$ Million) Table 237. Southeast Asia Prophylactic Gamma Globulin Revenue (2021-2032) & (US$ Million) Table 238. SAMEA Prophylactic Gamma Globulin Revenue by Type (2021-2026) & (US$ Million) Table 239. SAMEA Prophylactic Gamma Globulin Revenue by Type (2027-2032) & (US$ Million) Table 240. SAMEA Prophylactic Gamma Globulin Sales by Type (2021-2026) & (k units) Table 241. SAMEA Prophylactic Gamma Globulin Sales by Type (2027-2032) & (k units) Table 242. SAMEA Prophylactic Gamma Globulin Sales Price by Type (2021-2026) & (US$/unit) Table 243. SAMEA Prophylactic Gamma Globulin Sales Price by Type (2027-2032) & (US$/unit) Table 244. SAMEA Prophylactic Gamma Globulin Revenue by Application (2021-2026) & (US$ Million) Table 245. SAMEA Prophylactic Gamma Globulin Revenue by Application (2027-2032) & (US$ Million) Table 246. SAMEA Prophylactic Gamma Globulin Sales by Application (2021-2026) & (k units) Table 247. SAMEA Prophylactic Gamma Globulin Sales by Application (2027-2032) & (k units) Table 248. SAMEA Prophylactic Gamma Globulin Sales Price by Application (2021-2026) & (US$/unit) Table 249. SAMEA Prophylactic Gamma Globulin Sales Price by Application (2027-2032) & (US$/unit) Table 250. SAMEA Prophylactic Gamma Globulin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 251. SAMEA Prophylactic Gamma Globulin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 252. SAMEA Prophylactic Gamma Globulin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 253. SAMEA Prophylactic Gamma Globulin Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 254. SAMEA Prophylactic Gamma Globulin Sales by Country (2021-2026) & (k units) Table 255. SAMEA Prophylactic Gamma Globulin Sales by Country (2027-2032) & (k units) Table 256. SAMEA Prophylactic Gamma Globulin Sales Price by Country (2021-2026) & (US$/unit) Table 257. SAMEA Prophylactic Gamma Globulin Sales Price by Country (2027-2032) & (US$/unit) Table 258. Brazil Prophylactic Gamma Globulin Revenue (2021-2032) & (US$ Million) Table 259. Argentina Prophylactic Gamma Globulin Revenue (2021-2032) & (US$ Million) Table 260. Chile Prophylactic Gamma Globulin Revenue (2021-2032) & (US$ Million) Table 261. Colombia Prophylactic Gamma Globulin Revenue (2021-2032) & (US$ Million) Table 262. Peru Prophylactic Gamma Globulin Revenue (2021-2032) & (US$ Million) Table 263. Saudi Arabia Prophylactic Gamma Globulin Revenue (2021-2032) & (US$ Million) Table 264. Israel Prophylactic Gamma Globulin Revenue (2021-2032) & (US$ Million) Table 265. UAE Prophylactic Gamma Globulin Revenue (2021-2032) & (US$ Million) Table 266. Turkey Prophylactic Gamma Globulin Revenue (2021-2032) & (US$ Million) Table 267. Iran Prophylactic Gamma Globulin Revenue (2021-2032) & (US$ Million) Table 268. Egypt Prophylactic Gamma Globulin Revenue (2021-2032) & (US$ Million) Table 269. Key Raw Materials Table 270. Raw Materials Key Suppliers Table 271. Prophylactic Gamma Globulin Distributors List Table 272. Prophylactic Gamma Globulin Customers List Table 273. Research Programs/Design for This Report Table 274. Authors List of This Report Table 275. Secondary Sources Table 276. Primary Sources List of Figures Figure 1. Prophylactic Gamma Globulin Image Figure 2. Global Prophylactic Gamma Globulin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prophylactic Gamma Globulin Market Size Share 2021 VS 2025 VS 2032 Figure 4. IVIg Liquid Image Figure 5. IVIg Powder Image Figure 6. Global Prophylactic Gamma Globulin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Prophylactic Gamma Globulin Market Size Share 2021 VS 2025 VS 2032 Figure 8. Autoimmune Disease Image Figure 9. Immunodeficiency Image Figure 10. Acute Infection Image Figure 11. Global Prophylactic Gamma Globulin Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Prophylactic Gamma Globulin Revenue (2021-2032) & (US$ Million) Figure 13. Global Prophylactic Gamma Globulin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Prophylactic Gamma Globulin Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Prophylactic Gamma Globulin Revenue Market Share by Region (2021-2032) Figure 16. Global Prophylactic Gamma Globulin Sales (2021-2032) & (k units) Figure 17. Global Prophylactic Gamma Globulin Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 18. Global Prophylactic Gamma Globulin Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Prophylactic Gamma Globulin Sales YoY (2021-2032) & (k units) Figure 20. Europe Prophylactic Gamma Globulin Sales YoY (2021-2032) & (k units) Figure 21. China Prophylactic Gamma Globulin Sales YoY (2021-2032) & (k units) Figure 22. Asia (Excluding China) Prophylactic Gamma Globulin Sales YoY (2021-2032) & (k units) Figure 23. South America, Middle East and Africa Prophylactic Gamma Globulin Sales YoY (2021-2032) & (k units) Figure 24. Global Prophylactic Gamma Globulin Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Prophylactic Gamma Globulin Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Prophylactic Gamma Globulin Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Prophylactic Gamma Globulin Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Prophylactic Gamma Globulin Revenue Market Share by Type (2021-2032) Figure 30. Global Prophylactic Gamma Globulin Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 31. Global Prophylactic Gamma Globulin Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Prophylactic Gamma Globulin Sales Market Share by Type (2021-2032) Figure 33. Global Prophylactic Gamma Globulin Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Prophylactic Gamma Globulin Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Prophylactic Gamma Globulin Revenue Market Share by Application (2021-2032) Figure 36. Global Prophylactic Gamma Globulin Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 37. Global Prophylactic Gamma Globulin Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Prophylactic Gamma Globulin Sales Market Share by Application (2021-2032) Figure 39. North America Prophylactic Gamma Globulin Revenue Share by Type (2021-2032) Figure 40. North America Prophylactic Gamma Globulin Sales Share by Type (2021-2032) Figure 41. North America Prophylactic Gamma Globulin Revenue Share by Application (2021-2032) Figure 42. North America Prophylactic Gamma Globulin Sales Share by Application (2021-2032) Figure 43. North America Prophylactic Gamma Globulin Revenue Share by Country (2021-2032) Figure 44. North America Prophylactic Gamma Globulin Sales Share by Country (2021-2032) Figure 45. Europe Prophylactic Gamma Globulin Revenue Share by Type (2021-2032) Figure 46. Europe Prophylactic Gamma Globulin Sales Share by Type (2021-2032) Figure 47. Europe Prophylactic Gamma Globulin Revenue Share by Application (2021-2032) Figure 48. Europe Prophylactic Gamma Globulin Sales Share by Application (2021-2032) Figure 49. Europe Prophylactic Gamma Globulin Revenue Share by Country (2021-2032) Figure 50. Europe Prophylactic Gamma Globulin Sales Share by Country (2021-2032) Figure 51. China Prophylactic Gamma Globulin Revenue Share by Type (2021-2032) Figure 52. China Prophylactic Gamma Globulin Sales Share by Type (2021-2032) Figure 53. China Prophylactic Gamma Globulin Revenue Share by Application (2021-2032) Figure 54. China Prophylactic Gamma Globulin Sales Share by Application (2021-2032) Figure 55. Asia Prophylactic Gamma Globulin Revenue Share by Type (2021-2032) Figure 56. Asia Prophylactic Gamma Globulin Sales Share by Type (2021-2032) Figure 57. Asia Prophylactic Gamma Globulin Revenue Share by Application (2021-2032) Figure 58. Asia Prophylactic Gamma Globulin Sales Share by Application (2021-2032) Figure 59. Asia Prophylactic Gamma Globulin Revenue Share by Country (2021-2032) Figure 60. Asia Prophylactic Gamma Globulin Sales Share by Country (2021-2032) Figure 61. SAMEA Prophylactic Gamma Globulin Revenue Share by Type (2021-2032) Figure 62. SAMEA Prophylactic Gamma Globulin Sales Share by Type (2021-2032) Figure 63. SAMEA Prophylactic Gamma Globulin Revenue Share by Application (2021-2032) Figure 64. SAMEA Prophylactic Gamma Globulin Sales Share by Application (2021-2032) Figure 65. SAMEA Prophylactic Gamma Globulin Revenue Share by Country (2021-2032) Figure 66. SAMEA Prophylactic Gamma Globulin Sales Share by Country (2021-2032) Figure 67. Prophylactic Gamma Globulin Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Prophylactic Gamma Globulin Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • IVIg Liquid
  • IVIg Powder
Applications
  • Autoimmune Disease
  • Immunodeficiency
  • Acute Infection
Companies covered
  • CNBG
  • Takeda
  • Shenzhen Weiguang Biological
  • Beijing Tiantan Biological
  • CBPO
  • Sichuan Yuanda Shuyang
  • Shanghai RAAS
  • Pacific Shuanglin Bio-pharmacy
  • Grifols
  • Hualan Biological
  • Beijing Bohui Innovation Biotechnology
  • Baxter
  • Octapharma
  • LFB Group
  • Kedrion Biopharma
  • BPL
  • Biotest
  • ADMA Biologics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Prophylactic Gamma Globulin Market by Type
  3. 1.2.1 Global Prophylactic Gamma Globulin Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 IVIg Liquid
  5. 1.2.3 IVIg Powder
  6. 1.3 Prophylactic Gamma Globulin Market by Application
  7. 1.3.1 Global Prophylactic Gamma Globulin Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Autoimmune Disease
  9. 1.3.3 Immunodeficiency
  10. 1.3.4 Acute Infection
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Prophylactic Gamma Globulin Market Dynamics
  1. 2.1 Prophylactic Gamma Globulin Industry Trends
  2. 2.2 Prophylactic Gamma Globulin Industry Drivers
  3. 2.3 Prophylactic Gamma Globulin Industry Opportunities and Challenges
  4. 2.4 Prophylactic Gamma Globulin Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Prophylactic Gamma Globulin Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Prophylactic Gamma Globulin Revenue by Region
  3. 3.2.1 Global Prophylactic Gamma Globulin Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Prophylactic Gamma Globulin Revenue by Region (2021-2026)
  5. 3.2.3 Global Prophylactic Gamma Globulin Revenue by Region (2027-2032)
  6. 3.2.4 Global Prophylactic Gamma Globulin Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Prophylactic Gamma Globulin Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Prophylactic Gamma Globulin Sales by Region
  9. 3.4.1 Global Prophylactic Gamma Globulin Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Prophylactic Gamma Globulin Sales by Region (2021-2026)
  11. 3.4.3 Global Prophylactic Gamma Globulin Sales by Region (2027-2032)
  12. 3.4.4 Global Prophylactic Gamma Globulin Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Prophylactic Gamma Globulin Revenue by Manufacturers
  2. 4.1.1 Global Prophylactic Gamma Globulin Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Prophylactic Gamma Globulin Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Prophylactic Gamma Globulin Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Prophylactic Gamma Globulin Sales by Manufacturers
  6. 4.2.1 Global Prophylactic Gamma Globulin Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Prophylactic Gamma Globulin Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Prophylactic Gamma Globulin Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Prophylactic Gamma Globulin Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Prophylactic Gamma Globulin Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Prophylactic Gamma Globulin Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Prophylactic Gamma Globulin Manufacturers, Product Type & Application
  13. 4.7 Global Prophylactic Gamma Globulin Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Prophylactic Gamma Globulin Market CR5 and HHI
  16. 4.8.2 2025 Prophylactic Gamma Globulin Tier 1, Tier 2, and Tier 3
5 Prophylactic Gamma Globulin Market by Type
  1. 5.1 Global Prophylactic Gamma Globulin Revenue by Type
  2. 5.1.1 Global Prophylactic Gamma Globulin Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Prophylactic Gamma Globulin Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Prophylactic Gamma Globulin Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Prophylactic Gamma Globulin Sales by Type
  6. 5.2.1 Global Prophylactic Gamma Globulin Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Prophylactic Gamma Globulin Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Prophylactic Gamma Globulin Sales Market Share by Type (2021-2032)
  9. 5.3 Global Prophylactic Gamma Globulin Price by Type
6 Prophylactic Gamma Globulin Market by Application
  1. 6.1 Global Prophylactic Gamma Globulin Revenue by Application
  2. 6.1.1 Global Prophylactic Gamma Globulin Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Prophylactic Gamma Globulin Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Prophylactic Gamma Globulin Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Prophylactic Gamma Globulin Sales by Application
  6. 6.2.1 Global Prophylactic Gamma Globulin Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Prophylactic Gamma Globulin Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Prophylactic Gamma Globulin Sales Market Share by Application (2021-2032)
  9. 6.3 Global Prophylactic Gamma Globulin Price by Application
7 Company Profiles
  1. 7.1 CNBG
  2. 7.1.1 CNBG Company Information
  3. 7.1.2 CNBG Business Overview
  4. 7.1.3 CNBG Prophylactic Gamma Globulin Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 CNBG Prophylactic Gamma Globulin Product Portfolio
  6. 7.1.5 CNBG Recent Developments
  7. 7.2 Takeda
  8. 7.2.1 Takeda Company Information
  9. 7.2.2 Takeda Business Overview
  10. 7.2.3 Takeda Prophylactic Gamma Globulin Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Takeda Prophylactic Gamma Globulin Product Portfolio
  12. 7.2.5 Takeda Recent Developments
  13. 7.3 Shenzhen Weiguang Biological
  14. 7.3.1 Shenzhen Weiguang Biological Company Information
  15. 7.3.2 Shenzhen Weiguang Biological Business Overview
  16. 7.3.3 Shenzhen Weiguang Biological Prophylactic Gamma Globulin Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Shenzhen Weiguang Biological Prophylactic Gamma Globulin Product Portfolio
  18. 7.3.5 Shenzhen Weiguang Biological Recent Developments
  19. 7.4 Beijing Tiantan Biological
  20. 7.4.1 Beijing Tiantan Biological Company Information
  21. 7.4.2 Beijing Tiantan Biological Business Overview
  22. 7.4.3 Beijing Tiantan Biological Prophylactic Gamma Globulin Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Beijing Tiantan Biological Prophylactic Gamma Globulin Product Portfolio
  24. 7.4.5 Beijing Tiantan Biological Recent Developments
  25. 7.5 CBPO
  26. 7.5.1 CBPO Company Information
  27. 7.5.2 CBPO Business Overview
  28. 7.5.3 CBPO Prophylactic Gamma Globulin Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 CBPO Prophylactic Gamma Globulin Product Portfolio
  30. 7.5.5 CBPO Recent Developments
  31. 7.6 Sichuan Yuanda Shuyang
  32. 7.6.1 Sichuan Yuanda Shuyang Company Information
  33. 7.6.2 Sichuan Yuanda Shuyang Business Overview
  34. 7.6.3 Sichuan Yuanda Shuyang Prophylactic Gamma Globulin Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Sichuan Yuanda Shuyang Prophylactic Gamma Globulin Product Portfolio
  36. 7.6.5 Sichuan Yuanda Shuyang Recent Developments
  37. 7.7 Shanghai RAAS
  38. 7.7.1 Shanghai RAAS Company Information
  39. 7.7.2 Shanghai RAAS Business Overview
  40. 7.7.3 Shanghai RAAS Prophylactic Gamma Globulin Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Shanghai RAAS Prophylactic Gamma Globulin Product Portfolio
  42. 7.7.5 Shanghai RAAS Recent Developments
  43. 7.8 Pacific Shuanglin Bio-pharmacy
  44. 7.8.1 Pacific Shuanglin Bio-pharmacy Company Information
  45. 7.8.2 Pacific Shuanglin Bio-pharmacy Business Overview
  46. 7.8.3 Pacific Shuanglin Bio-pharmacy Prophylactic Gamma Globulin Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Pacific Shuanglin Bio-pharmacy Prophylactic Gamma Globulin Product Portfolio
  48. 7.8.5 Pacific Shuanglin Bio-pharmacy Recent Developments
  49. 7.9 Grifols
  50. 7.9.1 Grifols Company Information
  51. 7.9.2 Grifols Business Overview
  52. 7.9.3 Grifols Prophylactic Gamma Globulin Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Grifols Prophylactic Gamma Globulin Product Portfolio
  54. 7.9.5 Grifols Recent Developments
  55. 7.10 Hualan Biological
  56. 7.10.1 Hualan Biological Company Information
  57. 7.10.2 Hualan Biological Business Overview
  58. 7.10.3 Hualan Biological Prophylactic Gamma Globulin Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Hualan Biological Prophylactic Gamma Globulin Product Portfolio
  60. 7.10.5 Hualan Biological Recent Developments
  61. 7.11 Beijing Bohui Innovation Biotechnology
  62. 7.11.1 Beijing Bohui Innovation Biotechnology Company Information
  63. 7.11.2 Beijing Bohui Innovation Biotechnology Business Overview
  64. 7.11.3 Beijing Bohui Innovation Biotechnology Prophylactic Gamma Globulin Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Beijing Bohui Innovation Biotechnology Prophylactic Gamma Globulin Product Portfolio
  66. 7.11.5 Beijing Bohui Innovation Biotechnology Recent Developments
  67. 7.12 Baxter
  68. 7.12.1 Baxter Company Information
  69. 7.12.2 Baxter Business Overview
  70. 7.12.3 Baxter Prophylactic Gamma Globulin Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Baxter Prophylactic Gamma Globulin Product Portfolio
  72. 7.12.5 Baxter Recent Developments
  73. 7.13 Octapharma
  74. 7.13.1 Octapharma Company Information
  75. 7.13.2 Octapharma Business Overview
  76. 7.13.3 Octapharma Prophylactic Gamma Globulin Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Octapharma Prophylactic Gamma Globulin Product Portfolio
  78. 7.13.5 Octapharma Recent Developments
  79. 7.14 LFB Group
  80. 7.14.1 LFB Group Company Information
  81. 7.14.2 LFB Group Business Overview
  82. 7.14.3 LFB Group Prophylactic Gamma Globulin Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 LFB Group Prophylactic Gamma Globulin Product Portfolio
  84. 7.14.5 LFB Group Recent Developments
  85. 7.15 Kedrion Biopharma
  86. 7.15.1 Kedrion Biopharma Company Information
  87. 7.15.2 Kedrion Biopharma Business Overview
  88. 7.15.3 Kedrion Biopharma Prophylactic Gamma Globulin Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Kedrion Biopharma Prophylactic Gamma Globulin Product Portfolio
  90. 7.15.5 Kedrion Biopharma Recent Developments
  91. 7.16 BPL
  92. 7.16.1 BPL Company Information
  93. 7.16.2 BPL Business Overview
  94. 7.16.3 BPL Prophylactic Gamma Globulin Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 BPL Prophylactic Gamma Globulin Product Portfolio
  96. 7.16.5 BPL Recent Developments
  97. 7.17 Biotest
  98. 7.17.1 Biotest Company Information
  99. 7.17.2 Biotest Business Overview
  100. 7.17.3 Biotest Prophylactic Gamma Globulin Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Biotest Prophylactic Gamma Globulin Product Portfolio
  102. 7.17.5 Biotest Recent Developments
  103. 7.18 ADMA Biologics
  104. 7.18.1 ADMA Biologics Company Information
  105. 7.18.2 ADMA Biologics Business Overview
  106. 7.18.3 ADMA Biologics Prophylactic Gamma Globulin Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 ADMA Biologics Prophylactic Gamma Globulin Product Portfolio
  108. 7.18.5 ADMA Biologics Recent Developments
8 North America
  1. 8.1 North America Prophylactic Gamma Globulin Market Size by Type
  2. 8.1.1 North America Prophylactic Gamma Globulin Revenue by Type (2021-2032)
  3. 8.1.2 North America Prophylactic Gamma Globulin Sales by Type (2021-2032)
  4. 8.1.3 North America Prophylactic Gamma Globulin Price by Type (2021-2032)
  5. 8.2 North America Prophylactic Gamma Globulin Market Size by Application
  6. 8.2.1 North America Prophylactic Gamma Globulin Revenue by Application (2021-2032)
  7. 8.2.2 North America Prophylactic Gamma Globulin Sales by Application (2021-2032)
  8. 8.2.3 North America Prophylactic Gamma Globulin Price by Application (2021-2032)
  9. 8.3 North America Prophylactic Gamma Globulin Market Size by Country
  10. 8.3.1 North America Prophylactic Gamma Globulin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Prophylactic Gamma Globulin Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Prophylactic Gamma Globulin Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Prophylactic Gamma Globulin Market Size by Type
  2. 9.1.1 Europe Prophylactic Gamma Globulin Revenue by Type (2021-2032)
  3. 9.1.2 Europe Prophylactic Gamma Globulin Sales by Type (2021-2032)
  4. 9.1.3 Europe Prophylactic Gamma Globulin Price by Type (2021-2032)
  5. 9.2 Europe Prophylactic Gamma Globulin Market Size by Application
  6. 9.2.1 Europe Prophylactic Gamma Globulin Revenue by Application (2021-2032)
  7. 9.2.2 Europe Prophylactic Gamma Globulin Sales by Application (2021-2032)
  8. 9.2.3 Europe Prophylactic Gamma Globulin Price by Application (2021-2032)
  9. 9.3 Europe Prophylactic Gamma Globulin Market Size by Country
  10. 9.3.1 Europe Prophylactic Gamma Globulin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Prophylactic Gamma Globulin Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Prophylactic Gamma Globulin Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Prophylactic Gamma Globulin Market Size by Type
  2. 10.1.1 China Prophylactic Gamma Globulin Revenue by Type (2021-2032)
  3. 10.1.2 China Prophylactic Gamma Globulin Sales by Type (2021-2032)
  4. 10.1.3 China Prophylactic Gamma Globulin Price by Type (2021-2032)
  5. 10.2 China Prophylactic Gamma Globulin Market Size by Application
  6. 10.2.1 China Prophylactic Gamma Globulin Revenue by Application (2021-2032)
  7. 10.2.2 China Prophylactic Gamma Globulin Sales by Application (2021-2032)
  8. 10.2.3 China Prophylactic Gamma Globulin Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Prophylactic Gamma Globulin Market Size by Type
  2. 11.1.1 Asia Prophylactic Gamma Globulin Revenue by Type (2021-2032)
  3. 11.1.2 Asia Prophylactic Gamma Globulin Sales by Type (2021-2032)
  4. 11.1.3 Asia Prophylactic Gamma Globulin Price by Type (2021-2032)
  5. 11.2 Asia Prophylactic Gamma Globulin Market Size by Application
  6. 11.2.1 Asia Prophylactic Gamma Globulin Revenue by Application (2021-2032)
  7. 11.2.2 Asia Prophylactic Gamma Globulin Sales by Application (2021-2032)
  8. 11.2.3 Asia Prophylactic Gamma Globulin Price by Application (2021-2032)
  9. 11.3 Asia Prophylactic Gamma Globulin Market Size by Country
  10. 11.3.1 Asia Prophylactic Gamma Globulin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Prophylactic Gamma Globulin Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Prophylactic Gamma Globulin Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Prophylactic Gamma Globulin Market Size by Type
  2. 12.1.1 SAMEA Prophylactic Gamma Globulin Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Prophylactic Gamma Globulin Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Prophylactic Gamma Globulin Price by Type (2021-2032)
  5. 12.2 SAMEA Prophylactic Gamma Globulin Market Size by Application
  6. 12.2.1 SAMEA Prophylactic Gamma Globulin Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Prophylactic Gamma Globulin Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Prophylactic Gamma Globulin Price by Application (2021-2032)
  9. 12.3 SAMEA Prophylactic Gamma Globulin Market Size by Country
  10. 12.3.1 SAMEA Prophylactic Gamma Globulin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Prophylactic Gamma Globulin Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Prophylactic Gamma Globulin Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Prophylactic Gamma Globulin Value Chain Analysis
  2. 13.1.1 Prophylactic Gamma Globulin Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Prophylactic Gamma Globulin Production Mode & Process
  6. 13.2 Prophylactic Gamma Globulin Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Prophylactic Gamma Globulin Distributors
  9. 13.2.3 Prophylactic Gamma Globulin Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst